Hann Sung Yun, Cui Haitao, Chen Guibin, Boehm Manfred, Esworthy Timothy, Zhang Lijie Grace
Department of Mechanical and Aerospace Engineering, The George Washington University, Washington, DC 20052, USA.
Laboratory of Cardiovascular Regenerative Medicine, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD 20892, USA.
Biomed Eng Adv. 2022 Dec;4. doi: 10.1016/j.bea.2022.100065. Epub 2022 Nov 28.
Successful recovery from vascular diseases has typically relied on the surgical repair of damaged blood vessels (BVs), with the majority of current approaches involving the implantation of autologous BVs, which is plagued by donor site tissue damage. Researchers have attempted to develop artificial vessels as an alternative solution to traditional approaches to BV repair. However, the manufacturing of small-diameter (< 6 mm) BVs is still considered one of the biggest challenges due to its difficulty in the precise fabrication and the replication of biomimetic architectures. In this study, we successfully developed 3D printed flexible small-diameter BVs that consist of smooth muscle cells and a vascularized endothelium. In the developed artificial BV, a rubber-like elastomer was printed as the outermost layer of the vessel, which demonstrated enhanced mechanical properties, while and human induced pluripotent stem cell (iPSC)-derived vascular smooth muscle cells (iSMCs) and endothelial cells (iECs) embedded fibrinogen solutions were coaxially extruded with thrombin solution to form cell-laden fibrin gel inner layers. Our results showed that the 3D BVs possessed proper mechanical properties, and the cells in the fibrin layers substantially proliferated over time to form a stable BV construct. Our study demonstrated that the 3D printed flexible small-diameter BV using iPSCs could be a promising platform for the treatment of vascular diseases.
从血管疾病中成功康复通常依赖于对受损血管进行手术修复,目前大多数方法都涉及植入自体血管,但这会受到供体部位组织损伤的困扰。研究人员试图开发人造血管作为血管修复传统方法的替代解决方案。然而,小直径(<6毫米)血管的制造仍然被认为是最大的挑战之一,因为其精确制造和仿生结构的复制存在困难。在本研究中,我们成功开发了由平滑肌细胞和血管化内皮组成的3D打印柔性小直径血管。在所开发的人造血管中,一种类似橡胶的弹性体被打印为血管的最外层,其表现出增强的机械性能,而嵌入纤维蛋白原溶液中的人诱导多能干细胞(iPSC)衍生的血管平滑肌细胞(iSMCs)和内皮细胞(iECs)与凝血酶溶液同轴挤出,形成载有细胞的纤维蛋白凝胶内层。我们的结果表明,3D血管具有适当的机械性能,并且纤维蛋白层中的细胞随着时间的推移大量增殖,形成稳定的血管构建体。我们的研究表明,使用iPSC的3D打印柔性小直径血管可能是治疗血管疾病的一个有前景的平台。